BNTC - Benitec Biopharma Inc Company Long-Term Debt

Brandmark of Benitec Corp (BNTC)

The market trend visualized in monetary terms demonstrates the long-term liabilities of Benitec Biopharma Inc. (BNTC), which currently stand at 0.00. Company management is betting on the development of proprietary gene expression suppression methods and the expansion of its patent portfolio. The business relies on large-scale R&D investments to create precision treatments for severe pathologies. The startup's dynamics are independent of the economy, determined exclusively by the progress of medical trials.

Benitec Biopharma Inc (BNTC) Company Long-Term Debt: for the period 07/04/2022 - 10/29/2026

Benitec - analytical breakdowns and key metrics (BNTC)

- market price and analyst price targets:
Stock Price benitec.com|BNTC - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Benitec Biopharma|BNTC - Enterprise Value
- business book valuation details:
Net Asset Value per Share Benitec Biopharma|BNTC - Company Book Value|Capitalization to Book Value Ratio benitec.com|BNTC - Company Total Assets
- business debt structure and liquidity details:
Total Debt to Capital Coefficient Benitec Biopharma Inc.|BNTC - Long-Term Debt to Equity Ratio|Short-Term Loans to Capital Ratio Benitec Corp|BNTC - Company Aggregate Debts|Debts to Book Value Benitec Biopharma|BNTC - Company Long-Term Debts|Company Current Liabilities Benitec Biopharma|Intermediate Coverage Ratio benitec.com
- earnings and market multiples details:
BNTC - Net Profit
Summary company analytics:Benitec Biopharma Inc.
Signature product of Benitec Biopharma Inc

An analysis of the capital structure allows for the separation of sustainable development from speculative growth. For Benitec Biopharma Inc. (BNTC), which develops gene silencing platforms, long-term financing is critical when implementing complex R&D projects. The size of the issuer's long-term liabilities reflects the volume of borrowed funds with a maturity of more than one year, revealing the degree of dependence on creditors. The stability of this metric confirms the financial autonomy of Benitec Biopharma Inc. (BNTC) amidst the technological race.

Who Benitec Biopharma Inc. competes with

Company Long-Term Debts Tempus Labs TEM|Qiagen - Company Long-Term Debts|IONS: Company Long-Term Debt|RGEN: Company Long-Term Debts|Long-Term Debt Avidity Corp (RNA)|Company Long-Term Debt CRISPR Therapeutics AG|Company Long-Term Indebtedness WGS (genedx.com)|Company Long-Term Debts RARE|Long-Term Debt Volume Beam Therapeutics Inc|Sarepta Therapeutics Inc - Company Long-Term Liabilities|Amount of Long-Term Liabilities TWST (Twist Bioscience Corp)|10x Genomics, Inc. - Company Long-Term Debts|Long-Term Debt intelliatx.com|STOK: Company Long-Term Debts|Company Long-Term Liabilities BioLife Solutions Inc|Company Long-Term Liabilities WVE|MAZE: Company Long-Term Loans and Borrowings|Company Long-Term Debts SION|Company Long-Term Debt PRME (primemedicine.com)|Company Long-Term Debts TSHA (Taysha Gene Therapies, Inc.)|Long-Term Debt Volume uniQure NV (QURE)|MGTX - Company Long-Term Debt|Long-Term Debt REGENXBIO Corp|Solid Biosciences Inc. (SLDB) - Company Long-Term Debt|Long-Term Liabilities OCGN (ocugen.com)|PACB (PacBio) - Company Long-Term Debts|DSGN: Company Long-Term Loans and Borrowings|Company Long-Term Debts RCKT|Company Long-Term Debts 4D Molecular Corp (FDMT)|Company Long-Term Debt Lexeo Therapeutics, Inc. LXEO|Company Long-Term Loans and Borrowings KRRO|EDIT - Company Long-Term Debt|Silence Therapeutics PLC (SLN) - Company Long-Term Liabilities|PRQR: Company Long-Term Debts|Codexis (CDXS) - Company Long-Term Debts|Company Long-Term Liabilities SGMO|NAUT: Company Long-Term Loans and Borrowings|Company Long-Term Debts MGX|Long-Term Debt Volume Precision BioSciences Inc.|Company Long-Term Debt Generation Bio GBIO|BOLD: Company Long-Term Indebtedness|Exicure Corp - Company Long-Term Debts|Imunon, Inc. (IMNN) - Company Long-Term Liabilities|PHIO (phiopharma.com) - Company Long-Term Liabilities|MBIO - Long-Term Debt Volume|RNAZ (TransCode Therapeutics Inc.) - Company Long-Term Debts|Company Long-Term Debt BNGO|Company Long-Term Debt Applied DNA Sciences (APDN)|bluebirdbio.com - Company Long-Term Indebtedness|ImmunoPrecise Antibodies Ltd. - Company Long-Term Liabilities|Amount of Long-Term Liabilities OMGA (Omega Therapeutics Inc)|Singular Genomics Systems Inc - Company Long-Term Debts|Regulus (RGLS) - Company Long-Term Liabilities|SYRS: Company Long-Term Debts|Company Long-Term Indebtedness TBIO|Company Long-Term Debt TRACON Pharmaceuticals, Inc.|Company Long-Term Indebtedness UBX (Unity Biotechnology Inc.)